Nutex Health (NASDAQ:NUTX) Stock Gets Downgrade from Wall Street Zen

Nutex Health (NASDAQ:NUTX) was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a report issued on Saturday, Wall Street Zen reports.

Several other equities analysts also recently weighed in on the stock. Zacks Research downgraded shares of Nutex Health from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 6th. Weiss Ratings raised shares of Nutex Health from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Tuesday, October 6th. LADENBURG THALM/SH SH started coverage on Nutex Health in a research note on Monday, October 26th. They issued a “buy” rating and a $336.00 price objective on the stock. B. Riley Financial reaffirmed a “buy” rating on shares of Nutex Health in a research note on Friday, September 4th. Finally, Lake Street Capital reissued a “buy” rating and issued a $310.00 price objective (up from $235.00) on shares of Nutex Health in a research report on Tuesday, August 11th. Four research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $323.67.

Nutex Health Stock Performance

NUTX opened at $200.15 on Friday. Nutex Health has a 1 year low of $83.99 and a 1 year high of $226.16. The company has a debt-to-equity ratio of 0.59, a current ratio of 5.00 and a quick ratio of 4.96. The business has a fifty day simple moving average of $203.24 and a 200 day simple moving average of $150.70. The company has a market capitalization of $1.37 billion, a PE ratio of 7.86 and a beta of 0.66.

Nutex Health (NASDAQ:NUTX) last posted its quarterly earnings results on Thursday, August 6th. The company reported $9.38 earnings per share for the quarter, beating analysts’ consensus estimates of $4.95 by $4.43. The company had revenue of $210.75 million for the quarter, compared to the consensus estimate of $215.03 million. Nutex Health had a net margin of 21.25% and a return on equity of 39.74%. Research analysts expect that Nutex Health will post 26.65 EPS for the current year.

Insider Transactions at Nutex Health

In related news, Director Scott Saunders sold 203 shares of the firm’s stock in a transaction dated Friday, September 18th. The stock was sold at an average price of $214.25, for a total transaction of $43,492.75. Following the transaction, the director owned 400 shares of the company’s stock, valued at $85,700. This trade represents a 33.67% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 44.68% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. Allworth Financial LP grew its holdings in Nutex Health by 41.0% during the second quarter. Allworth Financial LP now owns 203 shares of the company’s stock worth $35,000 after acquiring an additional 59 shares during the period. Sterling Capital Management LLC boosted its holdings in Nutex Health by 9.1% in the third quarter. Sterling Capital Management LLC now owns 1,771 shares of the company’s stock valued at $375,000 after acquiring an additional 148 shares during the last quarter. Kilter Group LLC acquired a new position in shares of Nutex Health in the 2nd quarter valued at $27,000. VIRGINIA RETIREMENT SYSTEMS ET Al raised its position in Nutex Health by 3.8% in the 3rd quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 5,500 shares of the company’s stock valued at $1,164,000 after buying an additional 200 shares during the last quarter. Finally, Corient Private Wealth LP raised its position in Nutex Health by 5.1% during the second quarter. Corient Private Wealth LP now owns 6,684 shares of the company’s stock worth $1,142,000 after acquiring an additional 325 shares in the last quarter. Institutional investors and hedge funds own 5.32% of the company’s stock.

About Nutex Health

Nutex Health, Inc (NASDAQ:NUTX) is a physician-led healthcare services company that operates an integrated network of hospitals, medical facilities and physician practices in the United States. The company focuses on providing convenient, community-based care through its micro-hospitals and other healthcare locations.

Its hospital operations generally include emergency services, inpatient care, diagnostic testing and outpatient treatment. Nutex also operates physician networks and supports primary care and specialty providers.